Immunotec Inc.

Immunotec Inc.

May 24, 2011 16:30 ET

IMMUNOTEC Signs Material Contract With Glanbia Nutritionals

VAUDREUIL-DORION, QUEBEC--(Marketwire - May 24, 2011) - Immunotec Inc. (TSX VENTURE:IMM) a Canadian based company and a leader in the wellness industry (the "Company"), today announced that it has entered into a five (5) year Supply and Manufacturing Agreement with Glanbia Nutritional ("Glanbia").

Glanbia has been a strategic partner and the exclusive distributors of a proprietary Whey Protein Isolate used in the formulation of Immunocal and Immunocal Plus products. This new contract supersedes the expiration of a previous agreement signed in 2005.

"We are very excited to be solidifying our partnership with Glanbia" said Bob Henry, Immunotec's Executive Chairman and CEO. "The quality and responsiveness of Glanbia to support us is well appreciated".

About Immunotec Inc.

Immunotec is a world class business opportunity supported by unique scientifically proven products that improve wellness. Headquartered with manufacturing facilities near Montreal, Canada, the Company also has distribution capacities to support its commercial activities in Canada and internationally to the United States, Europe, Mexico and The Caribbean.

The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at and on the Company's website at The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM.

About Glanbia Nutritionals (NA), Inc.

Glanbia Nutritionals is a division of Glanbia plc, an international cheese and nutritional ingredients group headquartered in Kilkenny, Ireland. The Group has 4,300 employees worldwide with operations in Ireland, the UK, Germany, USA, Canada and China, as well as strategic international joint ventures in the UK, USA and Nigeria. Glanbia is listed on both the Dublin and London Stock Exchange.

Glanbia is the largest dairy processor in Ireland and a global supplier of nutritional ingredients, functional ingredients, and customized premix solutions. Glanbia Nutritionals is on the forefront in the exploration of science and the dynamics that drive the growing nutrition industry.


Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.

"The TSX Venture does not accept responsibility for the adequacy or accuracy of this release."

Contact Information